Abstract

Vaccines represent one of the most successful public health interventions in history, preventing millions of deaths annually and contributing to the control and eradication of infectious diseases worldwide. Despite their remarkable success, traditional vaccine platforms face limitations in terms of production scalability, stability, and immunogenicity against emerging pathogens. This article reviews recent advances in vaccine design and delivery systems that address these challenges and expand the potential of immunization strategies. Key innovations in vaccine design include recombinant protein vaccines, messenger RNA platforms, viral vector systems, and subunit approaches that offer improved safety profiles and targeted immune responses. Parallel developments in delivery systems, particularly nanoparticle carriers, liposomal formulations, and mucosal administration routes, have enhanced vaccine stability, immunogenicity, and patient compliance. These technological advances have demonstrated significant impacts on immune response optimization, reduction of adverse events, and improved accessibility in resource-limited settings. The rapid development and deployment of COVID-19 vaccines exemplified the potential of modern platforms to respond to pandemic threats with unprecedented speed. Looking forward, next generation vaccines incorporating adjuvant technologies, thermostable formulations, and personalized immunization strategies promise to further transform disease prevention. This review synthesizes current knowledge on vaccine innovation and identifies critical areas for future research to achieve universal vaccine coverage and prepare for emerging infectious disease threats.